CLINICAL_TRIALS
trial_result
· 2022-07-28
Clinical Trial Update: A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes [Phase 2]
Summary
A Phase 2 crossover trial evaluating postprandial glucose after a mixed meal tolerance test and metabolic effects of insulin withdrawal in adults with Type 1 di…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Youngene Therapeutics Inc., Ltd. | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED